Case Report
BibTex RIS Cite

Primary Membranous Glomerulonephritis in a Young Patient with Proteinuria

Year 2021, Volume: 3 Issue: Supplement 1, 65 - 66, 07.03.2021
https://doi.org/10.46310/tjim.876058
https://izlik.org/JA63ZK75YW

Abstract

Membranous nephropathy is a common form of glomerulonephritis that typically presents with nephrotic syndrome between the 3rd and 5th decades and one-third of patients experience spontaneous remission. Here, a patient with primary membranous nephropathy is presented.

References

  • Steinhäuslin F, Wauters JP. Quantitation of proteinuria in kidney transplant patients: accuracy of the urinary protein/creatinine ratio. Clin Nephrol. 1995 Feb;43(2):110-5.
  • Hoxha E, Harendza S, Pinnschmidt H, Panzer U, Stahl RA. PLA2R antibody levels and clinical outcome in patients with membranous nephropathy and non-nephrotic range proteinuria under treatment with inhibitors of the renin-angiotensin system. PLoS One. 2014 Oct 14;9(10):e110681. doi: 10.1371/journal.pone.0110681.
  • Ronco P, Debiec H. Pathophysiology of extramembranous glomerulopathies. Fifty years of progress, from laboratory to patient. Biol Aujourdhui. 2013;207(4):249-59 (in French). doi: 10.1051/jbio/2013025.
  • Hoxha E, Kneißler U, Stege G, Zahner G, Thiele I, Panzer U, Harendza S, Helmchen UM, Stahl RA. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Kidney Int. 2012 Oct;82(7):797-804. doi: 10.1038/ki.2012.209.
  • Bomback AS, Gharavi AG. Can genetics risk-stratify patients with membranous nephropathy? J Am Soc Nephrol. 2013 Jul;24(8):1190-2. doi: 10.1681/ASN.2013060576.
  • Debiec H, Hanoy M, Francois A, Guerrot D, Ferlicot S, Johanet C, Aucouturier P, Godin M, Ronco P. Recurrent membranous nephropathy in an allograft caused by IgG3κ targeting the PLA2 receptor. J Am Soc Nephrol. 2012 Dec;23(12):1949-54. doi: 10.1681/ASN.2012060577.
  • Larsen CP, Messias NC, Silva FG, Messias E, Walker PD. Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies. Mod Pathol. 2013 May;26(5):709-15. doi: 10.1038/modpathol.2012.207.
  • Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009 Jul 2;361(1):11-21. doi: 10.1056/NEJMoa0810457.

Year 2021, Volume: 3 Issue: Supplement 1, 65 - 66, 07.03.2021
https://doi.org/10.46310/tjim.876058
https://izlik.org/JA63ZK75YW

Abstract

References

  • Steinhäuslin F, Wauters JP. Quantitation of proteinuria in kidney transplant patients: accuracy of the urinary protein/creatinine ratio. Clin Nephrol. 1995 Feb;43(2):110-5.
  • Hoxha E, Harendza S, Pinnschmidt H, Panzer U, Stahl RA. PLA2R antibody levels and clinical outcome in patients with membranous nephropathy and non-nephrotic range proteinuria under treatment with inhibitors of the renin-angiotensin system. PLoS One. 2014 Oct 14;9(10):e110681. doi: 10.1371/journal.pone.0110681.
  • Ronco P, Debiec H. Pathophysiology of extramembranous glomerulopathies. Fifty years of progress, from laboratory to patient. Biol Aujourdhui. 2013;207(4):249-59 (in French). doi: 10.1051/jbio/2013025.
  • Hoxha E, Kneißler U, Stege G, Zahner G, Thiele I, Panzer U, Harendza S, Helmchen UM, Stahl RA. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Kidney Int. 2012 Oct;82(7):797-804. doi: 10.1038/ki.2012.209.
  • Bomback AS, Gharavi AG. Can genetics risk-stratify patients with membranous nephropathy? J Am Soc Nephrol. 2013 Jul;24(8):1190-2. doi: 10.1681/ASN.2013060576.
  • Debiec H, Hanoy M, Francois A, Guerrot D, Ferlicot S, Johanet C, Aucouturier P, Godin M, Ronco P. Recurrent membranous nephropathy in an allograft caused by IgG3κ targeting the PLA2 receptor. J Am Soc Nephrol. 2012 Dec;23(12):1949-54. doi: 10.1681/ASN.2012060577.
  • Larsen CP, Messias NC, Silva FG, Messias E, Walker PD. Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies. Mod Pathol. 2013 May;26(5):709-15. doi: 10.1038/modpathol.2012.207.
  • Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009 Jul 2;361(1):11-21. doi: 10.1056/NEJMoa0810457.
There are 8 citations in total.

Details

Primary Language English
Subjects ​Internal Diseases
Journal Section Case Report
Authors

Ece Ünal Çetin 0000-0002-0933-7764

Adil Uğur Çetin 0000-0002-2640-5386

Submission Date February 7, 2021
Acceptance Date March 6, 2021
Publication Date March 7, 2021
DOI https://doi.org/10.46310/tjim.876058
IZ https://izlik.org/JA63ZK75YW
Published in Issue Year 2021 Volume: 3 Issue: Supplement 1

Cite

APA Ünal Çetin, E., & Çetin, A. U. (2021). Primary Membranous Glomerulonephritis in a Young Patient with Proteinuria. Turkish Journal of Internal Medicine, 3(Supplement 1), 65-66. https://doi.org/10.46310/tjim.876058
AMA 1.Ünal Çetin E, Çetin AU. Primary Membranous Glomerulonephritis in a Young Patient with Proteinuria. Turk J Int Med. 2021;3(Supplement 1):65-66. doi:10.46310/tjim.876058
Chicago Ünal Çetin, Ece, and Adil Uğur Çetin. 2021. “Primary Membranous Glomerulonephritis in a Young Patient With Proteinuria”. Turkish Journal of Internal Medicine 3 (Supplement 1): 65-66. https://doi.org/10.46310/tjim.876058.
EndNote Ünal Çetin E, Çetin AU (March 1, 2021) Primary Membranous Glomerulonephritis in a Young Patient with Proteinuria. Turkish Journal of Internal Medicine 3 Supplement 1 65–66.
IEEE [1]E. Ünal Çetin and A. U. Çetin, “Primary Membranous Glomerulonephritis in a Young Patient with Proteinuria”, Turk J Int Med, vol. 3, no. Supplement 1, pp. 65–66, Mar. 2021, doi: 10.46310/tjim.876058.
ISNAD Ünal Çetin, Ece - Çetin, Adil Uğur. “Primary Membranous Glomerulonephritis in a Young Patient With Proteinuria”. Turkish Journal of Internal Medicine 3/Supplement 1 (March 1, 2021): 65-66. https://doi.org/10.46310/tjim.876058.
JAMA 1.Ünal Çetin E, Çetin AU. Primary Membranous Glomerulonephritis in a Young Patient with Proteinuria. Turk J Int Med. 2021;3:65–66.
MLA Ünal Çetin, Ece, and Adil Uğur Çetin. “Primary Membranous Glomerulonephritis in a Young Patient With Proteinuria”. Turkish Journal of Internal Medicine, vol. 3, no. Supplement 1, Mar. 2021, pp. 65-66, doi:10.46310/tjim.876058.
Vancouver 1.Ece Ünal Çetin, Adil Uğur Çetin. Primary Membranous Glomerulonephritis in a Young Patient with Proteinuria. Turk J Int Med. 2021 Mar. 1;3(Supplement 1):65-6. doi:10.46310/tjim.876058

30994   34277 29166

 

Turkish Journal of Internal Medicine, hosted by DERGİPARK, is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

by-nc-nd.png